Nuveen’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.4M | Sell |
762,777
-315,417
| -29% | -$16.3M | 0.01% | 670 |
|
|
2026
Q1 | $54.8M | Sell |
1,078,194
-46,508
| -4% | -$2.17M | 0.01% | 604 |
|
|
2025
Q4 | $33.2M | Buy |
1,124,702
+22,533
| +2% | +$612K | 0.01% | 848 |
|
|
2025
Q3 | $28.5M | Buy |
1,102,169
+163,719
| +17% | +$4.57M | 0.01% | 919 |
|
|
2025
Q2 | $25.9M | Buy |
938,450
+250,254
| +36% | +$6.59M | 0.01% | 939 |
|
|
2025
Q1 | $19.5M | Buy |
688,196
+16,017
| +2% | +$568K | 0.01% | 1145 |
|
|
2024
Q4 | $27.9M | Sell |
672,179
-9,998
| -1% | -$478K | 0.01% | 965 |
|
|
2024
Q3 | $45.6M | Sell |
682,177
-63,923
| -9% | -$5.87M | 0.01% | 708 |
|
|
2024
Q2 | $88.6M | Sell |
746,100
-60,194
| -7% | -$7.62M | 0.03% | 439 |
|
|
2024
Q1 | $85.9M | Sell |
806,294
-114,355
| -12% | -$11.5M | 0.03% | 458 |
|
|
2023
Q4 | $91.6M | Sell |
920,649
-38,413
| -4% | -$3.23M | 0.03% | 421 |
|
|
2023
Q3 | $99.1M | Sell |
959,062
-10,352
| -1% | -$1.15M | 0.03% | 371 |
|
|
2023
Q2 | $118M | Sell |
969,414
-48,081
| -5% | -$6.41M | 0.04% | 340 |
|
|
2023
Q1 | $156M | Sell |
1,017,495
-11,978
| -1% | -$1.98M | 0.06% | 278 |
|
|
2022
Q4 | $185M | Buy |
1,029,473
+93,423
| +10% | +$15.3M | 0.07% | 249 |
|
|
2022
Q3 | $111M | Sell |
936,050
-61,815
| -6% | -$9.38M | 0.04% | 351 |
|
|
2022
Q2 | $143M | Sell |
997,865
-69,932
| -7% | -$10M | 0.06% | 302 |
|
|
2022
Q1 | $187M | Sell |
1,067,797
-12,767
| -1% | -$2.15M | 0.06% | 277 |
|
|
2021
Q4 | $274M | Sell |
1,080,564
-191,840
| -15% | -$56.1M | 0.08% | 219 |
|
|
2021
Q3 | $490M | Sell |
1,272,404
-207,313
| -14% | -$76.5M | 0.15% | 133 |
|
|
2021
Q2 | $348M | Buy |
1,479,717
+298,009
| +25% | +$53.3M | 0.1% | 185 |
|
|
2021
Q1 | $155M | Sell |
1,181,708
-165,428
| -12% | -$24M | 0.05% | 336 |
|
|
2020
Q4 | $141M | Buy |
1,347,136
+577,249
| +75% | +$58.4M | 0.05% | 350 |
|
|
2020
Q3 | $54.5M | Sell |
769,887
-299,121
| -28% | -$20.9M | 0.02% | 551 |
|
|
2020
Q2 | $68.6M | Buy |
1,069,008
+256,011
| +31% | +$14M | 0.03% | 473 |
|
|
2020
Q1 | $24.3M | Buy |
812,997
+89,937
| +12% | +$2.07M | 0.01% | 796 |
|
|
2019
Q4 | $13.8M | Sell |
723,060
-14,651
| -2% | -$260K | 0.01% | 1395 |
|
|
2019
Q3 | $11.7M | Buy |
737,711
+643,967
| +687% | +$9.51M | ﹤0.01% | 1463 |
|
|
2019
Q2 | $1.37M | Buy |
+93,744
| New | +$2.01M | ﹤0.01% | 2611 |
|
Other funds holding MRNA
TP
Nuveen's MRNA Position: Q2 2026 in Review
Nuveen reduced its Moderna (MRNA) stake by 29% in Q2 2026, selling an estimated $16.3M and leaving 762,777 shares worth $53.4M. The position accounts for 0.01% of the portfolio, ranked #670.
Nuveen first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $490M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Nuveen held 762,777 shares of Moderna worth $53.4M as of Q2 2026.
- Nuveen sold 315,417 Moderna shares in Q2 2026, an estimated $16.3M.
- Moderna made up 0.01% of Nuveen's portfolio in Q2 2026, its #670 holding.
- Nuveen first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
- Nuveen's Moderna position peaked at $490M in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.